SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hikal gets nod to raise Rs 375 crore through NCDs

14 Feb 2022 Evaluate

Hikal has received approval to raise Rs 375 crore through 3750 Unrated, unlisted, secured, redeemable, Non-Convertible Debentures (NCDs) on private placement basis. Date of maturity will be 8 years from the date of allotment. The Board of Directors of the Company at its meeting held on February 14, 2022, has approved the same.

Hikal is a leading manufacturer and supplier of API's and intermediates globally.

Hikal Share Price

192.15 3.60 (1.91%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×